R. Pfab

624 total citations
24 papers, 390 citations indexed

About

R. Pfab is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, R. Pfab has authored 24 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in R. Pfab's work include Lung Cancer Treatments and Mutations (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (3 papers). R. Pfab is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (3 papers). R. Pfab collaborates with scholars based in Germany and United States. R. Pfab's co-authors include K. Havemann, M Wolf, K.-H. Pflüger, S. Harder, A. H. Staib, D. Loew, E.H. Graul, M. Maasberg, M. Wolf and Rainer Seitz and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

R. Pfab

23 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Pfab Germany 8 174 145 53 42 37 24 390
V. V. Yakusevich Russia 11 75 0.4× 53 0.4× 58 1.1× 11 0.3× 53 1.4× 23 581
Hee-Jung Sohn South Korea 8 176 1.0× 165 1.1× 12 0.2× 12 0.3× 25 0.7× 20 351
R. Berberich Germany 9 48 0.3× 73 0.5× 12 0.2× 43 1.0× 73 2.0× 33 349
C Brambilla France 8 73 0.4× 153 1.1× 22 0.4× 35 0.8× 49 1.3× 30 327
Kotaro Kitani Japan 12 113 0.6× 128 0.9× 50 0.9× 49 1.2× 163 4.4× 45 366
Marie Cullberg Sweden 10 141 0.8× 198 1.4× 14 0.3× 35 0.8× 61 1.6× 27 570
Jesus M. Matos United States 11 315 1.8× 95 0.7× 28 0.5× 17 0.4× 250 6.8× 21 486
D C Doll United States 8 84 0.5× 100 0.7× 37 0.7× 39 0.9× 76 2.1× 14 471
Z. R. Desai United Kingdom 10 194 1.1× 35 0.2× 65 1.2× 13 0.3× 18 0.5× 15 397
Brent T. Xia United States 15 177 1.0× 167 1.2× 59 1.1× 7 0.2× 152 4.1× 25 456

Countries citing papers authored by R. Pfab

Since Specialization
Citations

This map shows the geographic impact of R. Pfab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Pfab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Pfab more than expected).

Fields of papers citing papers by R. Pfab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Pfab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Pfab. The network helps show where R. Pfab may publish in the future.

Co-authorship network of co-authors of R. Pfab

This figure shows the co-authorship network connecting the top 25 collaborators of R. Pfab. A scholar is included among the top collaborators of R. Pfab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Pfab. R. Pfab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pflüger, K.-H., et al.. (1996). Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer.. Journal of Clinical Oncology. 14(4). 1071–1076. 96 indexed citations
3.
Pfab, R., et al.. (1996). [Do an operation and radiotherapy in the breast-preserving therapy of breast carcinoma modify the meaningfulness of subsequent mammographies?].. PubMed. 172(8). 455–9. 2 indexed citations
4.
Pfab, R., et al.. (1995). [Radiotherapy of degenerative inflammatory joint diseases in the elderly. A worthwhile therapeutic measure].. PubMed. 113(22-23). 323–4. 3 indexed citations
5.
Wolf, M, et al.. (1995). Paclitaxel and simultaneous radiation in the treatment of stage III A/B non-small cell lung cancer.. PubMed. 22(6 Suppl 14). 108–12. 19 indexed citations
6.
7.
Pfab, R., et al.. (1994). [The inhibition of the proliferation and energy metabolism of Cloudman melanoma cells in vitro by aphidicolin and gamma radiation].. PubMed. 170(6). 352–8. 3 indexed citations
8.
Seitz, Rainer, Michael Kraus, M. Wolf, et al.. (1993). Activation of coagulation and fibrinolysis in patients with lung cancer. Blood Coagulation & Fibrinolysis. 4(2). 249–254. 71 indexed citations
9.
Wolf, M., et al.. (1992). Carboplatin and Simultaneous Radiation in the Treatment of Stage III A/B Non-Small Cell Lung Cancer. Oncology. 49(1). 71–77. 7 indexed citations
10.
Paul, N, et al.. (1992). [Electron microscopic studies on the effects of irradiation and mitoxantrone hydrochloride (Novantrone), alone and in combination, on cells of Harding-Passey melanoma in monolayer culture].. PubMed. 168(6). 361–8. 1 indexed citations
11.
Havemann, K., et al.. (1992). Preclincal and clinical experience with cisplatin and carboplatin and simultaneous radiation in non-small cell lung cancer. Annals of Oncology. 3. S33–S37. 11 indexed citations
12.
Wolf, M., M. Maasberg, R. Pfab, & K. Havemann. (1991). Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines. Journal of Cancer Research and Clinical Oncology. 117(S4). S187–S192. 3 indexed citations
13.
Köppler, H., Karl-Heinz Pflüger, R. Pfab, et al.. (1991). Sequential versus alternating chemotherapy for high grade non‐hodgkin's lymphomas: A randomized multicentre trial. Hematological Oncology. 9(4-5). 217–223. 5 indexed citations
14.
Köppler, H., Karl-Heinz Pflüger, R. Pfab, et al.. (1990). Sequential versus Alternating Chemotherapy for High-Grade Non-Hodgkin’s Lymphomas: Preliminary Results of a Phase III Multicentre Trial. Oncology Research and Treatment. 13(1). 28–32. 1 indexed citations
15.
Köppler, H., R. Pfab, K. Lennert, et al.. (1989). CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study. British Journal of Cancer. 60(1). 79–82. 18 indexed citations
16.
Pfab, R., et al.. (1988). Augmentation by L-dopa of growth inhibition and melanin formation of X-irradiated Harding-Passey melanoma cells in culture.. PubMed. 164(7). 419–24. 6 indexed citations
17.
Köppler, H., Karl-Heinz Pflüger, R. Pfab, et al.. (1987). Multizentrische Studie zur Behandlung hochmaligner Non-Hodgkin-Lymphome mit Polychemotherapie (CHOPV) und Bestrahlung. Oncology Research and Treatment. 10(1). 34–40.
18.
Staib, A. H., D. Loew, S. Harder, E.H. Graul, & R. Pfab. (1986). Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device. European Journal of Clinical Pharmacology. 30(6). 691–697. 67 indexed citations
19.
Pfab, R., et al.. (1985). [Ultrastructural studies of the effect of x-rays and quinacrine (Atebrin) or chloroquine (Resochin)--alone or in combination--on Harding-Passey melanoma cells in monolayer culture].. PubMed. 161(11). 711–8. 5 indexed citations
20.
Biller, Hugh F., et al.. (1982). [Influence of x-rays and quinacrine (atebrine) or chloroquine (resochine)--alone or in combination--on growth and melanin formation of Harding-Passey melanoma cells in monolayer culture].. PubMed. 158(7). 450–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026